Tablets - 25 mg
Cinnarizine is a H1 receptor antagonist and a calcium channel blocker. Cinnarizine inhibits the transmission of calcium ions in the smooth muscle cells of arteries and causes vasodilatation. Cinnarizine is an effective therapeutic agent for the treatment of labyrinth disorders. It has anti-vasoconstrictor activity and therefore it is used to improve symptoms caused by poor cerebral and peripheral perfusion. Cinnarizine does not affect blood pressure and heart rate.
Cinarizine tablets are indicated in:
Oral drops solution – (10.000 UI + 10.000 UI) / ml
Sugar-coated tablets – 10 mg
Film-coated tablets – 400 mg
Film-coated tablets – 600 mg
Solution for injection - (0.1%) 1 mg/1 ml